What Are Systemic Disease Causes of Oral Ulcers?
Discussion Oral ulcers are common problems seen by dentists but pediatricians also see them. Usually families have are concerned because they are painful and acute. Ulcers are sometime noticed by the physician and not the family as in the case of herpangina or hand-foot and mouth disease. Chronic or recurrent ulcerations present less commonly and therefore it may be more difficult to determine their etiology. Many of the systemic disease causes of oral ulcers are overall infrequent and/or not common in the pediatric age range. Ulcers can be classified in several ways but acute ulcers are usually painful and last less tha...
Source: PediatricEducation.org - September 21, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

University of South Carolina study reveals how cannabinoids may be useful to prevent colon cancer
(University of South Carolina) Inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis are caused by inflammation of the gastrointestinal tract. Patients with IBD are at a higher risk of developing colorectal cancer. A UofSC study shows that THC suppressed inflammation in the colon, preventing the onset of cancers caused by a carcinogen. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 15, 2020 Category: Cancer & Oncology Source Type: news

Survival Mortality Ulcerative Colitis
Survival and Cause-Specific Mortality in Ulcerative Colitis (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 11, 2020 Category: General Medicine Source Type: news

Ulcerative Colitis
Title: Ulcerative ColitisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/2/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 2, 2020 Category: Nutrition Source Type: news

What Is Ulcerative Colitis, the Ailment Afflicting Shinzo Abe of Japan?
The disease that has afflicted Prime Minister Shinzo Abe of Japan is a chronic malady that can strike at a young age and flare up unpredictably. (Source: NYT Health)
Source: NYT Health - August 28, 2020 Category: Consumer Health News Authors: Rick Gladstone Tags: Digestive Tract Colitis Bowels Crohn ' s Disease Colon Clinical Gastroenterology and Hepatology (Journal) Massachusetts General Hospital Abe, Shinzo Source Type: news

Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
In an oversubscribed round, top-tier investors provide significant financial resources to accelerate clinical development of potentially best-in-class therapies for inflammatory/autoimmune diseases SAN DIEGO and TAICANG, SUZHOU, China, Aug. 24, 2020 -- ... Biopharmaceuticals, Venture Capital, Personnel Connect Biopharma, atopic dermatitis, ulcerative colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 24, 2020 Category: Pharmaceuticals Source Type: news

Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis
Basel, 10 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced topline results from its phase III study programme evaluating the investigational medicine etrolizumab in people with moderately to severely active ulcerative colitis. Mixed results were seen in studies evaluating etrolizumab as an induction therapy, and both studies evaluating etrolizumab as a maintenance therapy failed to meet their primary endpoints, showing no significant difference in the proportion of people achieving remission with subcutaneous etrolizumab versus placebo. In the HIBISCUS I induction study, in people without prior anti-tumour ...
Source: Roche Media News - August 10, 2020 Category: Pharmaceuticals Source Type: news

Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis
Basel, 10 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced topline results from its phase III study programme evaluating the investigational medicine etrolizumab in people with moderately to severely active ulcerative colitis. Mixed results were seen in studies evaluating etrolizumab as an induction therapy, and both studies evaluating etrolizumab as a maintenance therapy failed to meet their primary endpoints, showing no significant difference in the proportion of people achieving remission with subcutaneous etrolizumab versus placebo. In the HIBISCUS I induction study, in people without prior anti-tumour ...
Source: Roche Investor Update - August 10, 2020 Category: Pharmaceuticals Source Type: news

What Is the Life Expectancy of Someone With Ulcerative Colitis?
Title: What Is the Life Expectancy of Someone With Ulcerative Colitis?Category: Diseases and ConditionsCreated: 8/6/2020 12:00:00 AMLast Editorial Review: 8/6/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 6, 2020 Category: Nutrition Source Type: news

How Serious Is Ulcerative Colitis?
Title: How Serious Is Ulcerative Colitis?Category: Diseases and ConditionsCreated: 8/6/2020 12:00:00 AMLast Editorial Review: 8/6/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 6, 2020 Category: Nutrition Source Type: news

An interspecies translation model implicates integrin signaling in infliximab-resistant inflammatory bowel disease
Anti–tumor necrosis factor (anti-TNF) therapy resistance is a major clinical challenge in inflammatory bowel disease (IBD), due, in part, to insufficient understanding of disease-site, protein-level mechanisms. Although proteomics data from IBD mouse models exist, data and phenotype discrepancies contribute to confounding translation from preclinical animal models of disease to clinical cohorts. We developed an approach called translatable components regression (TransComp-R) to overcome interspecies and trans-omic discrepancies between mouse models and human subjects. TransComp-R combines mouse proteomic data with pa...
Source: Signal Transduction Knowledge Environment - August 4, 2020 Category: Science Authors: Brubaker, D. K., Kumar, M. P., Chiswick, E. L., Gregg, C., Starchenko, A., Vega, P. N., Southard-Smith, A. N., Simmons, A. J., Scoville, E. A., Coburn, L. A., Wilson, K. T., Lau, K. S., Lauffenburger, D. A. Tags: STKE Research Articles Source Type: news

High-Fiber, Low-Fat Diet for Ulcerative Colitis
Title: High-Fiber, Low-Fat Diet for Ulcerative ColitisCategory: Health NewsCreated: 7/10/2020 12:00:00 AMLast Editorial Review: 7/13/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 13, 2020 Category: Nutrition Source Type: news

High-Fiber, Low-Fat Diet May Help People With Ulcerative Colitis
FRIDAY, July 10, 2020 -- A low-fat, high-fiber diet may improve the quality of life of patients with ulcerative colitis, a new study finds. " Patients with inflammatory bowel disease always ask us what they should eat to make their symptoms better, " ... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 10, 2020 Category: General Medicine Source Type: news

Inflammatory Bowel Disease Tied to Increased Dementia Risk
Those with Crohn ’s disease or ulcerative colitis had higher rates of Alzheimer’s disease and other forms of dementia. (Source: NYT Health)
Source: NYT Health - July 2, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Alzheimer ' s Disease Dementia Digestive Tract Crohn Source Type: news

Better Data Shed More Light on Ulcerative Colitis Surgery Better Data Shed More Light on Ulcerative Colitis Surgery
An inflammatory bowel disease (IBD) surgery registry that adds IBD-specific variables to general quality measurements for restorative proctocolectomy with ileal pouch-anal anastomosis (RPC-IPAA) performed for ulcerative colitis (UC) allows a better interpretation of predictive factors for delayed pouch formation, according to a new study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 1, 2020 Category: Surgery Tags: Gastroenterology News Source Type: news

Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab in Systemic Lupus Erythematosus
SPRING HOUSE, PENNSYLVANIA, June 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today its decision to discontinue the Phase 3 LOTUS study of STELARA® (ustekinumab) in Systemic Lupus Erythematosus (SLE) due to lack of efficacy in SLE.The decision is based on data from a pre-planned interim efficacy analysis. Interim safety findings were consistent with the known safety profile of STELARA, and no new safety signals were identified. Investigators, study participants and health authorities have been informed of the decision. The company intends to thoroughly analyze the totality of...
Source: Johnson and Johnson - June 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Long-term Response to I.V. Steroids in Acute Severe UC Long-term Response to I.V. Steroids in Acute Severe UC
This study assessed relapse-free survival in patients with acute severe ulcerative colitis who have responding favorably to treatment with intravenous steroids.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 24, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Could Crohn's, Colitis Raise Dementia Risk?
TUESDAY, June 23, 2020 -- People with inflammatory bowel disease might be vulnerable to developing dementia, a new study suggests. Inflammatory bowel disease, or IBD, is an umbrella term for ulcerative colitis and Crohn's disease. Both cause chronic... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 23, 2020 Category: General Medicine Source Type: news

Is Ulcerative Colitis Curable?
Title: Is Ulcerative Colitis Curable?Category: Diseases and ConditionsCreated: 6/19/2020 12:00:00 AMLast Editorial Review: 6/19/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 19, 2020 Category: Nutrition Source Type: news

Adaptation of the BSG guidelines on the management of acute severe ulcerative colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel, BSG
Management of acute severe ulcerative colitis (ASUC) during the novel coronavirus 2019 (COVID-19) pandemic presents significant dilemmas. We aimed to provide COVID-19-specific guidance using current British Society of Gastroenterology (BSG) guidelines as a reference point. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 10, 2020 Category: Consumer Health News Source Type: news

Understanding a gene's role in inflammatory bowel disease
(University of California - Riverside) A protein-coding gene associated with autoimmune diseases such as Crohn's disease and ulcerative colitis, collectively referred to as inflammatory bowel disease, or IBD, will be the focus of new research in the School of Medicine at the University of California, Riverside. The work is made possible by a National Institutes of Health grant exceeding $2.5 million. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2020 Category: International Medicine & Public Health Source Type: news

Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals
Gilead Sciences Inc and partner Galapagos NV said on Wednesday a higher dose of their experimental drug filgotinib showed greater effectiveness than placebo in a mid-stage study testing it in ulcerative colitis patients. (Source: Reuters: Health)
Source: Reuters: Health - May 20, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Vedolizumab and Infliximab in UC After Failure of Anti-TNF Vedolizumab and Infliximab in UC After Failure of Anti-TNF
In this study, in patients with ulcerative colitis refractory to an anti-TNF agent, vedolizumab was more effective than infliximab in achieving clinical remission.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 13, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Fecal Calprotectin and Histologic Remission in UC Fecal Calprotectin and Histologic Remission in UC
Might fecal calprotectin be useful as a non-invasive marker of histologic remission in patients with ulcerative colitis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 13, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

The effects of inflammatory bowel disease on pregnancy
(Wiley) Inflammatory bowel disease (IBD) -- including Crohn's disease and ulcerative colitis -- often affects women of childbearing age. A study published in Alimentary Pharmacology& Therapeutics compared the health of pregnant and non-pregnant women with IBD. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 8, 2020 Category: International Medicine & Public Health Source Type: news

Researchers explore the effects of a plant compound called resveratrol in patients with ulcerative colitis
(Natural News) People suffering from ulcerative colitis can benefit from a plant compound found in red wine and chocolate. A recent study published in the Archives of Medical Research revealed that resveratrol can improve the quality of life of patients with ulcerative colitis. What is ulcerative colitis? Ulcerative colitis is a chronic disease that affects the inner... (Source: NaturalNews.com)
Source: NaturalNews.com - April 7, 2020 Category: Consumer Health News Source Type: news

Patients and RWE: Is this the year?
The long-hyped redefinition of healthcare through wearable tech has been … well, long hyped. Early projects, such as Apple HealthKit and Fitbit, were undoubtably important in redefining ‘the possible’ but they haven’t yet achieved transformative application.  Much has been written on why the philosophy that has driven the astonishing success of consumer technology doesn ’t translate to healthcare and when we look at the state of innovation in 2020, many of these structural issues remain.   As Emily Cerciello, Associate Director, Digital Health and Engagement at the Crohn's...
Source: EyeForPharma - March 26, 2020 Category: Pharmaceuticals Authors: Tom Disley Source Type: news

Patients and RWE: Is this the year?
The long-hyped redefinition of healthcare through wearable tech has been … well, long hyped. Early projects, such as Apple HealthKit and Fitbit, were undoubtably important in redefining ‘the possible’ but they haven’t yet achieved transformative application.  Much has been written on why the philosophy that has driven the astonishing success of consumer technology doesn ’t translate to healthcare and when we look at the state of innovation in 2020, many of these structural issues remain.   As Emily Cerciello, Associate Director, Digital Health and Engagement at the Crohn's...
Source: EyeForPharma - March 26, 2020 Category: Pharmaceuticals Authors: Tom Disley Source Type: news

Patients and RWE: Is this the year?
The long-hyped redefinition of healthcare through wearable tech has been … well, long hyped. Early projects, such as Apple HealthKit and Fitbit, were undoubtably important in redefining ‘the possible’ but they haven’t yet achieved transformative application.  Much has been written on why the philosophy that has driven the astonishing success of consumer technology doesn ’t translate to healthcare and when we look at the state of innovation in 2020, many of these structural issues remain.   As Emily Cerciello, Associate Director, Digital Health and Engagement at the Crohn's...
Source: EyeForPharma - March 26, 2020 Category: Pharmaceuticals Authors: Tom Disley Source Type: news

FDA approves ozanimod, a drug invented at Scripps Research, for multiple sclerosis
(Scripps Research Institute) The US Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 26, 2020 Category: International Medicine & Public Health Source Type: news

Using 'organs-on-a-chip' to model complicated diseases
(Massachusetts Institute of Technology) MIT biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system on a microfluidic chip seeded with human cells. With this 'organs-on-a-chip' model, they could explore the role of immune cells in ulcerative colitis and other inflammatory diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2020 Category: International Medicine & Public Health Source Type: news

Endoscopic Improvement and Remission in Ulcerative Colitis Endoscopic Improvement and Remission in Ulcerative Colitis
What proportion of ulcerative colitis patients with self-reported symptom resolution after treatment have residual endoscopic activity that might warrant additional therapy?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 9, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Consumer Health: Inflammatory bowel disease and colon cancer screening
If you have inflammatory bowel disease, you may be worried about colon cancer. Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, is an umbrella term used to describe disorders that involve chronic inflammation of your digestive tract. It's important to understand that while inflammatory bowel disease increases your risk of colon cancer, it doesn't necessarily [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 6, 2020 Category: Databases & Libraries Source Type: news

Crohn's Disease, Ulcerative Colitis, and Lipid Profiles Crohn's Disease, Ulcerative Colitis, and Lipid Profiles
The population-based study evaluated the association of developing IBD with serum lipid profiles. Did Crohn's disease and ulcerative colitis patients differ in their profile characteristics?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 4, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Recommendations Provided for Treatment of Ulcerative Colitis
WEDNESDAY, March 4, 2020 -- In a new clinical guideline from the American Gastroenterological Association, recently published in Gastroenterology, treatment recommendations are presented for patients with moderate-to-severe ulcerative colitis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 4, 2020 Category: Pharmaceuticals Source Type: news

Ulcerative colitis: bacteria findings raise hopes for new treatment
Sufferers found to have low levels of gut microbes that convert bile acids into other substancesHopes of developing a new treatment for ulcerative colitis have been raised by research suggesting the condition may be linked to low levels of certain bacteria in the gut.Ulcerative colitis is a long-term condition in whichthe colon becomes inflamed. Accordingto the NHS, it is thought to be an autoimmune disease and affects one in every 420 people in the UK. Sufferers need to empty their bowels frequently, develop ulcers in their colon and have recurring bouts of diarrhoea with blood and pus in the faeces.Continue reading... (S...
Source: Guardian Unlimited Science - February 25, 2020 Category: Science Authors: Nicola Davis Tags: Digestive disorders Science Health & wellbeing Life and style Society Source Type: news

Risk of Relapse Among Patients With UC in Endoscopic Remission Risk of Relapse Among Patients With UC in Endoscopic Remission
This study aimed to quantify the association between histologic activity and clinical relapse among patients with ulcerative colitis who were in complete endoscopic remission.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 24, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Tofacitinib Maintenance Dose for Patients With UC Tofacitinib Maintenance Dose for Patients With UC
This study analyzed the efficacy and safety of two adjustments of tofacitinib maintenance dosing for patients with ulcerative colitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 3, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Biologics May Have Changed the Natural History of Ulcerative Colitis Biologics May Have Changed the Natural History of Ulcerative Colitis
The rate of colectomy within the first year after hospital admission for ulcerative colitis has declined in the modern era of biologics, suggesting the advent of biologic therapy has changed the natural history of the disease, researchers report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 30, 2020 Category: Surgery Tags: Gastroenterology News Source Type: news

Vedolizumab and Malignancy Incidence Vedolizumab and Malignancy Incidence
This study analyzed the long-term incidence of malignancy with vedolizumab, a gut-selective antibody approved to treat moderate-to-severe Crohn's disease and ulcerative colitis in adults.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 22, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New AGA guideline outlines treatment best practices for ulcerative colitis patients
(American Gastroenterological Association) An increasing number of drugs are available for long-term management of moderate to severe UC, leading to questions about treatment strategies for optimal patient care. A new clinical guideline from the American Gastroenterological Association, published in Gastroenterology, the official journal of the AGA Institute, provides recommendations for the management of adult outpatients with moderate to severe UC as well as adult hospitalized patients with acute severe ulcerative colitis (ASUC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2020 Category: International Medicine & Public Health Source Type: news

Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis
Even after adjustment for tumor stage, patients with ulcerative colitis have higher risk for CRC mortality (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 17, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis
FRIDAY, Jan. 17, 2020 -- Patients with ulcerative colitis have an increased risk for colorectal cancer and colorectal cancer mortality, according to a study published in the Jan. 11 issue of The Lancet. Ola Ol én, M.D., from the Karolinska... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2020 Category: Pharmaceuticals Source Type: news

Fungal Alterations in Inflammatory Bowel Diseases Fungal Alterations in Inflammatory Bowel Diseases
This review explores the role of gut fungi in patients with Crohn's disease and ulcerative colitis. Might modulation of the fungal microbiota present a therapeutic opportunity for IBD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 15, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Colorectal cancer risk remains despite modern treatment for ulcerative colitis
(Karolinska Institutet) Patients with the inflammatory bowel disease ulcerative colitis have a higher risk of dying from colorectal cancer, despite modern therapy, even though the risk has declined in recent years. This is according to a new study published in the scientific journal The Lancet by a team of Swedish and Danish researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2020 Category: Cancer & Oncology Source Type: news

Ultrasound Effective in Monitoring Ulcerative Colitis Ultrasound Effective in Monitoring Ulcerative Colitis
Intestinal ultrasound (IUS) is an effective non-invasive tool for monitoring disease - and possibly treatment response - in patients with ulcerative colitis (UC), according to German researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 6, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

1999 to 2017 Saw Drop in IBD Hospitalization Rate for Whites
THURSDAY, Dec. 12, 2019 -- From 1999 to 2017, the hospitalization rate for Crohn disease and ulcerative colitis decreased among non-Hispanic white Medicare beneficiaries aged ≥65 years, but not among non-Hispanic blacks, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Xeljanz XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis
December 12, 2019 - Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Xeljanz XR (tofacitinib) extended-release 11 mg and 22 mg tablets for the once-daily treatment of adult patients with moderately... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 12, 2019 Category: Drugs & Pharmacology Source Type: news

A vaccine against chronic inflammatory diseases
Chronic inflammatory bowel diseases, such as Crohn's Disease and ulcerative colitis, are linked to abnormalities of the gut microbiota in humans and in animals. Patients generally present reduced bacterial diversity in their intestinal flora along with excessive levels of bacteria that express a protein called flagellin, which favors their mobility. (Source: World Pharma News)
Source: World Pharma News - December 11, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news